LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 60 filers reported holding LEAP THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,074 | -24.4% | 6,100 | 0.0% | 0.00% | – |
Q4 2022 | $2,745 | -45.1% | 6,100 | 0.0% | 0.00% | – |
Q3 2022 | $5,000 | -28.6% | 6,100 | 0.0% | 0.00% | – |
Q2 2022 | $7,000 | -36.4% | 6,100 | 0.0% | 0.00% | – |
Q1 2022 | $11,000 | -45.0% | 6,100 | 0.0% | 0.00% | – |
Q4 2021 | $20,000 | -16.7% | 6,100 | 0.0% | 0.00% | – |
Q3 2021 | $24,000 | +140.0% | 6,100 | 0.0% | 0.00% | – |
Q2 2021 | $10,000 | -16.7% | 6,100 | 0.0% | 0.00% | – |
Q1 2021 | $12,000 | -14.3% | 6,100 | 0.0% | 0.00% | – |
Q4 2020 | $14,000 | +16.7% | 6,100 | 0.0% | 0.00% | – |
Q3 2020 | $12,000 | -7.7% | 6,100 | 0.0% | 0.00% | – |
Q2 2020 | $13,000 | +30.0% | 6,100 | 0.0% | 0.00% | – |
Q1 2020 | $10,000 | +42.9% | 6,100 | 0.0% | 0.00% | – |
Q4 2019 | $7,000 | 0.0% | 6,100 | 0.0% | 0.00% | – |
Q3 2019 | $7,000 | -36.4% | 6,100 | 0.0% | 0.00% | – |
Q2 2019 | $11,000 | 0.0% | 6,100 | 0.0% | 0.00% | – |
Q1 2019 | $11,000 | -8.3% | 6,100 | 0.0% | 0.00% | – |
Q4 2018 | $12,000 | -75.0% | 6,100 | 0.0% | 0.00% | – |
Q3 2018 | $48,000 | – | 6,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 900,733 | $1,883,000 | 1.44% |
Sio Capital Management, LLC | 1,501,998 | $3,139,000 | 0.92% |
CVI Holdings, LLC | 704,900 | $1,473,000 | 0.55% |
Perceptive Advisors | 8,476,496 | $17,466,000 | 0.28% |
Artal Group S.A. | 2,974,000 | $6,216,000 | 0.17% |
SPHERA FUNDS MANAGEMENT LTD. | 880,000 | $1,839,000 | 0.17% |
DAFNA Capital Management LLC | 275,000 | $575,000 | 0.17% |
J. Goldman & Co LP | 1,018,285 | $2,128,000 | 0.13% |
MYDA Advisors LLC | 100,000 | $209,000 | 0.13% |
683 Capital Management, LLC | 526,466 | $1,100,000 | 0.09% |